CC-11006 is a immunomodulatory agent, is also an orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.
| Product Name | CC-11006 |
| Synonyms | |
| CAS Number | 444287-44-9 |
| Related CAS | |
| Molecular Formula | C18H17N3O5 |
| Molecular Weight | 355.35 |
| SMILES | O=C(NCC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O)C1CC1 |
| Purity (HPLC) | >= 95% |
| Physical Appearance | White solid |
| Solubility | DMSO, DMF |
| Shipping Conditions | Room Temperature |
| Storage Conditions | Refrigerated |
| Shelf Life | 12 months after the date of delivery |
| Regulatory Statement | For Research Use Only |
References
Hanan, E. J., Liang, J., Wang, X., Blake, R. A., Blaquiere, N.,Staben, S. T., Monomeric Targeted Protein Degraders. Journal of Medicinal Chemistry 2020, 63, 11330-11361.
Documents
Datasheet COA MSDS
Citations
If you know of a paper that uses this product from Tenova Pharma, please let us know.